Patents by Inventor Kenneth M. Weisman

Kenneth M. Weisman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7169768
    Abstract: A method of decreasing atherosclerosis and its complications including but not limited to myocardial infarction, stroke and peripheral vascular disease wherein the method involves administering to a human or an animal an amount of an inhibitor of the release of LHRH or GnRH.
    Type: Grant
    Filed: June 3, 1998
    Date of Patent: January 30, 2007
    Inventors: Kenneth M. Weisman, Michael Goldberg
  • Patent number: 6140315
    Abstract: A method of decreasing atherosclerosis and its complications, such as myocardial infarction, stroke and peripheral vascular disease, wherein the method involves administering to a human or an animal an amount of goserelin acetate sufficient to decrease atherosclerosis and its complications.
    Type: Grant
    Filed: June 5, 1998
    Date of Patent: October 31, 2000
    Inventors: Kenneth M. Weisman, Michael Goldberg
  • Patent number: 6099851
    Abstract: A method of decreasing atherosclerosis and its complications including but not limited to myocardial infarction, stroke and peripheral vascular disease comprising administering to a human or animal an amount of Leuprolide acetate is sufficient to decrease atherosclerosis and its complications.
    Type: Grant
    Filed: June 2, 1998
    Date of Patent: August 8, 2000
    Inventors: Kenneth M. Weisman, Michael Goldberg
  • Patent number: 6090409
    Abstract: The method of decreasing atherosclerosis and its complications, such as, myocardial infarction, stroke and peripheral vascular disease involving administering to a human or animal an amount of finasteride sufficient to decrease atherosclerosis and its complications.
    Type: Grant
    Filed: March 13, 1998
    Date of Patent: July 18, 2000
    Inventors: Kenneth M. Weisman, Michael Goldberg